Balkrishan Kalra - 13 Mar 2024 Form 4 Insider Report for Genpact LTD (G)

Role: President and CEO, Director
Signature: /s/ Thomas D. Scholtes, as Attorney-in-fact for Balkrishan Kalra
Issuer symbol: G
Transactions as of: 13 Mar 2024
Net transactions value: $0
Form type: 4
Filing time: 15 Mar 2024, 17:00:32 UTC
Previous filing: 12 Jan 2024
Next filing: 13 Sep 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	G	Common Shares	Award	$0	+96,848	+52%	$0.000000	283,404	13 Mar 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2025, January 10, 2026 and January 10, 2027, subject to the reporting person's continued service through each vesting date.
F2	Includes 719 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on January 12, 2024. The reporting person currently holds a total of 7,854 shares under the ESPP.

Content

Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2025, January 10, 2026 and January 10, 2027, subject to the reporting person's continued service through each vesting date.

Includes 719 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on January 12, 2024. The reporting person currently holds a total of 7,854 shares under the ESPP.